The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEfg-hold.gdr S Regulatory News (EFGD)

Share Price Information for Efg-hold.gdr S (EFGD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.70
Bid: 0.00
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.70 (0.00%)
Open: 0.70
High: 0.00
Low: 0.00
Prev. Close: 0.70
EFGD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3Q2019 Results

12 Nov 2019 07:34

RNS Number : 0863T
EFG-Hermes Holdings SAE
12 November 2019
 

http://www.rns-pdf.londonstockexchange.com/rns/0863T_1-2019-11-12.pdf

http://www.rns-pdf.londonstockexchange.com/rns/0863T_2-2019-11-12.pdf

EFG HERMES REPORTS THIRD QUARTER 2019

GROUP EARNINGS OF EGP358 MILLION; ON OPERATING REVENUE OF EGP1.2 BILLION

Cairo, November 12th, 2019 - EFG Hermes reports third quarter 2019, with Group Earnings of EGP358 million on operating revenues of EGP1.2 billion. The Group Total assets stood at EGP39.6 billion at the end of 3Q19.

Key Highlights

 

3Q2019

 

 

·; EFG Hermes posted another solid set of results reflecting its strong and diversified operations, with its Group revenues adding another 25% Y-o-Y to reach EGP1.2 billion in 3Q19; as both its Investment Bank and its NBFIs platforms reported strong Y-o-Y growth;

·; Fees and commissions, which represents 74% of the Group revenues, rose 13% Y-o-Y to EGP872 million, on the back of higher Brokerage and Tanmeyah's revenues;

·; The NBFIs platform continues to deliver strong results, with its revenues climbing 41% Y-o-Y to EGP299 million in 3Q19; underpinned by Tanmeyah's robust revenue growth, with its revenues rising 52% Y-o-Y to EGP252 million in 3Q19;

·; Sell-side revenues gained 11% to reach EGP490 million in 3Q19, on higher Brokerage revenues generated from Egypt, KSA and Structured Products, and despite lower Investment Banking revenues as the comparable 3Q18 was very strong;

·; Buy-side revenues declined 29% Y-o-Y to EGP84 million in 3Q19, on lower management fees booked by FIM. Meanwhile, Private Equity revenues came flat Y-o-Y in 3Q19;

·; Capital markets & treasury operations revenue contribution to the Group's total revenues came at 26% in 3Q19, with its revenues increasing 79% Y-o-Y to EGP302 million. Revenues were supported by net interest earned and realized capital gains;

·; Group operating expenses rose 20% to EGP721 million in 3Q19, mainly on the back of higher operating expenses related to Tanmeyah as its operations expanded Y-o-Y, and on higher variable expenses that increase in line with the increase in revenues. Moreover, the Investment Bank other operating expenses were broadly flat Y-o-Y;

·; The Group net operating profit and the net profit after tax and minority interest climbed 34% Y-o-Y to EGP453 million and EGP358 million, respectively; as the increase in revenues outweighed the increase in expenses.

 

For full report and financial statements, please click on the links on top of the page.

 

For further information:

Investor Relations Contacts

Email: investor-relations@efg-hermes.com

Group Head of IR, Budgeting and Reporting

Hanzada Nessim

Email: hnessim@efg-hermes.com

Tel: +20 (0)2 35356502

www.efg-hermes.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTLIFFDLLLFLIA
Date   Source Headline
26th Apr 20129:23 amRNSStatement re. Press Comment
25th Apr 20123:45 pmRNSSecond Price Monitoring Extn
25th Apr 20123:40 pmRNSPrice Monitoring Extension
10th Apr 20127:00 amRNSFY2011 Results
28th Mar 20129:36 amRNSStatement re Damas International Limited
26th Mar 20128:49 amRNSStatement re Strategic Alliance with QInvest
19th Mar 201211:07 amRNSStatement re. Press Comment
14th Feb 20129:33 amRNSStatement re CEO Travel Ban
8th Feb 20128:33 amRNSStatement re CEO Travel Ban
6th Feb 20127:42 amRNSStatement re - CEO Travel Ban
17th Jan 20123:45 pmRNSSecond Price Monitoring Extn
17th Jan 20123:40 pmRNSPrice Monitoring Extension
16th Nov 20119:28 amRNS3rd Quarter Results
10th Oct 20113:45 pmRNSSecond Price Monitoring Extn
10th Oct 20113:40 pmRNSPrice Monitoring Extension
4th Oct 20119:53 amRNSStatement re. Press Comment
19th Sep 20113:45 pmRNSSecond Price Monitoring Extn
19th Sep 20113:40 pmRNSPrice Monitoring Extension
19th Sep 20112:00 pmRNSStatement re Bonus Shares Distribution
2nd Sep 20113:40 pmRNSPrice Monitoring Extension
15th Aug 20117:00 amRNS2nd Quarter results
11th Aug 20113:45 pmRNSSecond Price Monitoring Extn
11th Aug 20113:40 pmRNSPrice Monitoring Extension
1st Aug 20113:45 pmRNSSecond Price Monitoring Extn
1st Aug 20113:40 pmRNSPrice Monitoring Extension
19th Jul 20113:45 pmRNSSecond Price Monitoring Extn
19th Jul 20113:40 pmRNSPrice Monitoring Extension
13th Jul 20113:45 pmRNSSecond Price Monitoring Extn
13th Jul 20113:40 pmRNSPrice Monitoring Extension
6th Jul 201111:53 amRNSRegulatory Approval
27th Jun 20113:45 pmRNSSecond Price Monitoring Extn
27th Jun 20113:40 pmRNSPrice Monitoring Extension
15th Jun 20119:28 amRNS1st Quarter Results
13th Jun 201110:36 amRNSEGM & AGM Statement
6th Jun 20117:00 amRNSTreasury Stock
25th May 20119:29 amRNSNotice of AGM & EGM
10th May 20113:40 pmRNSPrice Monitoring Extension
5th May 20113:45 pmRNSSecond Price Monitoring Extn
5th May 20113:40 pmRNSPrice Monitoring Extension
4th May 20113:40 pmRNSPrice Monitoring Extension
28th Apr 20113:40 pmRNSPrice Monitoring Extension
27th Apr 20111:12 pmRNSStatement re Board of Directors
26th Apr 20113:40 pmRNSPrice Monitoring Extension
26th Apr 201110:32 amRNSStatement re Board of Directors
18th Apr 20119:51 amRNSDirectorate Change
30th Mar 20112:19 pmRNSStatement re news published on the company
30th Mar 20119:47 amRNSAnnual Financial Report
29th Mar 20115:00 pmRNSDirectorate Change
14th Feb 20117:10 amRNSStatement re clarification of ownership
10th Feb 20113:45 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.